Medical device
To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM
Successful validation of standardized clinical procedure for instillation of nanoparticles in first patient cohort
AuroLase Therapy is a focal ablation treatment utilizing gold nanoparticles. The nanoparticles heat and destroy cancer cells.
Advanced composite alternative to steel tubing showcased in Booth #2141
Sernova Corp., a clinical-stage regenerative medicine company, is pleased to announce that it has completed a first closing of $2,333,500 of its non-brokered private placement, of which $64,000 was closed under the “Existing Shareholder Exemption.”
Saranas Inc. announced that it has been named one of Houston’s most innovative companies.
First patient enrolment at University of Cincinnati
The Journal of Medical Device Regulation’s recently redesigned website – www.GlobalRegulatoryPress.com – reflects the Journal’s emphasis on complete customer satisfaction.
Charles River Labs will open its CRADL facility in South San Francisco in January 2020 in order to provide flexible, turnkey vivarium rental space for startups.
CelGro® Human Nerve Regeneration Trial Recently Orthocell announced that the first four patients successfully completed participation in the CelGro® nerve regeneration clinical trial.
PRESS RELEASES